Navigation Links
Sunridge Advances its PNT Glaucoma Treatment Throughout China
Date:10/7/2010

FOUNTAIN HILLS, Ariz., Oct. 7 /PRNewswire/ -- Sunridge International (OTC Bulletin Board: SNDZ) said today that its patented Pneumatic Trabeculoplasty (PNT) non-invasive treatment for glaucoma and ocular hypertension, is making its mark in China.  Introduced into China by Beijing Vision World Trading Co. Ltd. (BVW), in 2007, the PNT treatment has undergone the most vigorous patient research studies before gaining regulatory approval by China's Federal Drug Administration earlier this year.

In recent months, Beijing Vision World had presented the PNT treatment at a number of ophthalmologist conferences, expert forums and hospital training seminars in a number of cities throughout China including Beijing, Nanjing, Taiyuan, Wuhan, Changsha and several towns throughout Northeast China. Research papers devoted to PNT have been presented by leading ophthalmic practitioners and academics at several conferences all of which have been reported in news articles and feature stories appearing in China's general and technical publications.  Details of the treatment and its impact on glaucoma patients, have been featured on national TV programs.  More information regarding these events can be viewed at www.visionworld.com.cn.

In summarizing his firm's progress, Mr. Yang Waisheng, President of BVW, said he and his marketing team were extremely pleased with the reception given by some of China's most demanding ophthalmologists, eye doctors and hospitals throughout China. "We have made a very good start and it is our intention to continue to demonstrate the PNT approach to the treatment of glaucoma.  Our goal is to have PNT taken up by an increasing number of hospitals, clinics and ophthalmic surgeries in China so that we might reach out to as many glaucoma sufferers as possible throughout this vast country.  We are conscious of the fact that many of these patients would otherwise be unable to find treatment to control this pervasive eye disease which is so prevalent in China."

G. Richard Smith, CEO of Sunridge International, said that China represents an enormous marketing opportunity for the PNT equipment and treatment.  "We are delighted with the progress and sales made by Mr. Yang and his team each month and we are determined to provide maximum sales and marketing support to bear on their efforts to bringing our treatment to the tremendous number of outlets in China."CONTACT:Jeff Smith, Sunridge International  T:  +1-480-837-6165e-mail: info@sunridgeint.comwebsite: www.sunridgeint.comMEDIA:Victor Webb, Marston Webb InternationalT: (212) 684-6601e-mail: marwebint@cs.com
'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic
2. Sunridge Schedules European Meetings
3. Sunridge Ships First Order to the Middle East
4. Sunridge to Introduce Their PNT Treatment for Glaucoma to Medical Personnel in India
5. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
6. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
7. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
8. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
9. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
10. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
11. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... PUNE, India , January 24, 2017 ... Allied Market Research, titled, "Cold Chain Logistics Market by ... & Frozen Dessert, Meat, Fish & Sea Food, Drugs ... Industry Forecasts, 2014-2022," projects that the global cold chain ... 2022, growing at a CAGR of 16% (2016 to ...
(Date:1/24/2017)... Analysis of the Liquid Biopsy Market by ... - our new study reveals trends, R&D progress, and predicted revenues ... involved in this sector you must read this brand new report. ... 2027, assessing data, trends, opportunities and business prospects there. ... Discover How to Stay Ahead ...
(Date:1/24/2017)... Md. , and GAITHERSBURG, Md. , ... XON ), a leader in the engineering and industrialization ... of the planet, today announced that it has entered into ... GNVC ), a clinical-stage company and pioneer in ... Intrexon intends to integrate and expand upon GenVec,s expertise in ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... PeroxyChem Food and ... Control Equipment (PACE), at the International Production and Processing Expo (IPPE) in Atlanta, ... the new technology that is used in poultry processing facilities to provide constant, ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... advance to the semi-final round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired ... its 12th year in 2017. The entrepreneurs will showcase their businesses on February ...
(Date:1/24/2017)... ... ... Bellus Medical, a leader in medical aesthetics, today announced that Marek Dobke, ... Dobke will provide physician oversight for in-house clinical studies and hands-on device training, among ... Associate Professor of Surgery at UC San Diego Health and is a board certified ...
(Date:1/24/2017)... MA (PRWEB) , ... January 24, 2017 , ... ... They Really Need to Thrive , Well-meaning studies such as the Fordham Institute’s ... schools can better serve top students, such as including gifted or high-achieving students ...
(Date:1/24/2017)... ... 2017 , ... Today, Taza Agua, Costa Rica's leading supplier ... to optimize the drinking experience for K-Cup coffee, tea and hot chocolate connoisseurs ... first untouched bottled water purposed exclusively for creating a superior brew. The company ...
Breaking Medicine News(10 mins):